Understand the source comparison
How Peptides for Plantar Fasciitis Target Tissue Repair: BPC-157 vs TB-500 Mechanisms
BPC-157 Upregulates VEGF and FGF to increase capillary density; modulates TGF-β1 to reduce inflammatory cytokines Daily (250–500 mcg) Localized. Within 2–3 cm of plantar fascia Accelerates collagen synthesis and tensile strength recovery Best for acute microte
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- Upregulates VEGF and FGF to increase capillary density; modulates TGF-β1 to reduce inflammatory cytokines
- Daily (250–500 mcg)
- Localized. Within 2–3 cm of plantar fascia
- Accelerates collagen synthesis and tensile strength recovery
- Best for acute microtears and early-stage inflammation. Works faster but requires daily administration
- TB-500
- Promotes actin polymerization for cell migration; downregulates NF-κB to limit chronic inflammation
- Twice weekly during loading phase (2–5 mg)
- Systemic. Any subcutaneous site
- Enhances fibroblast migration and reduces scar tissue formation
- Best for chronic cases with established fibrosis. Slower onset but longer-lasting systemic effects
- Combination Protocol
- Synergistic. BPC-157 builds new tissue while TB-500 prevents excessive fibrosis
- BPC daily + TB twice weekly
- BPC localized, TB systemic
- Optimal balance of repair speed and tissue quality
- Recommended for plantar fasciitis lasting >3 months. Addresses both active inflammation and tissue remodeling